Mitochondria-Targeted Antioxidants for Treatment of Hearing Loss: A Systematic Review

被引:79
作者
Fujimoto, Chisato [1 ,2 ]
Yamasoba, Tatsuya [1 ]
机构
[1] Univ Tokyo, Grad Sch Med, Dept Otolaryngol & Head & Neck Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan
[2] Tokyo Teishin Hosp, Dept Otolaryngol, Chiyoda Ku, 2-14-23 Fujimi, Tokyo 1028798, Japan
基金
日本学术振兴会;
关键词
antioxidants; hearing loss; mitochondria; reactive oxygen species; CISPLATIN-INDUCED OTOTOXICITY; ACETYL-L-CYSTEINE; HAIR CELL-SURVIVAL; L-N-ACETYLCYSTEINE; GENTAMICIN OTOTOXICITY; OXIDATIVE STRESS; NOISE EXPOSURE; COENZYME Q(10); DOUBLE-BLIND; PLASTOQUINONE DERIVATIVES;
D O I
10.3390/antiox8040109
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mitochondrial dysfunction is associated with the etiologies of sensorineural hearing loss, such as age-related hearing loss, noise- and ototoxic drug-induced hearing loss, as well as hearing loss due to mitochondrial gene mutation. Mitochondria are the main sources of reactive oxygen species (ROS) and ROS-induced oxidative stress is involved in cochlear damage. Moreover, the release of ROS causes further damage to mitochondrial components. Antioxidants are thought to counteract the deleterious effects of ROS and thus, may be effective for the treatment of oxidative stress-related diseases. The administration of mitochondria-targeted antioxidants is one of the drug delivery systems targeted to mitochondria. Mitochondria-targeted antioxidants are expected to help in the prevention and/or treatment of diseases associated with mitochondrial dysfunction. Of the various mitochondria-targeted antioxidants, the protective effects of MitoQ and SkQR1 against ototoxicity have been previously evaluated in animal models and/or mouse auditory cell lines. MitoQ protects against both gentamicin- and cisplatin-induced ototoxicity. SkQR1 also provides auditory protective effects against gentamicin-induced ototoxicity. On the other hand, decreasing effect of MitoQ on gentamicin-induced cell apoptosis in auditory cell lines has been controversial. No clinical studies have been reported for otoprotection using mitochondrial-targeted antioxidants. High-quality clinical trials are required to reveal the therapeutic effect of mitochondria-targeted antioxidants in terms of otoprotection in patients.
引用
收藏
页数:19
相关论文
共 190 条
[1]   Cisplatin-induced apoptotic cell death in Mongolian gerbil cochlea [J].
Alam, SA ;
Ikeda, K ;
Oshima, T ;
Suzuki, M ;
Kawase, T ;
Kikuchi, T ;
Takasaka, T .
HEARING RESEARCH, 2000, 141 (1-2) :28-38
[2]   Protective effects of mitochondria-targeted antioxidant SkQ in aqueous and lipid membrane environments [J].
Antonenko, Y. N. ;
Roginsky, V. A. ;
Pashkovskaya, A. A. ;
Rokitskaya, T. I. ;
Kotova, E. A. ;
Zaspa, A. A. ;
Chernyak, B. V. ;
Skulachev, V. P. .
JOURNAL OF MEMBRANE BIOLOGY, 2008, 222 (03) :141-149
[3]   Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 1. Cationic plastoquinone derivatives: Synthesis and in vitro studies [J].
Antonenko, Y. N. ;
Avetisyan, A. V. ;
Bakeeva, L. E. ;
Chernyak, B. V. ;
Chertkov, V. A. ;
Domnina, L. V. ;
Ivanova, O. Yu. ;
Izyumov, D. S. ;
Khailova, L. S. ;
Klishin, S. S. ;
Korshunova, G. A. ;
Lyamzaev, K. G. ;
Muntyan, M. S. ;
Nepryakhina, O. K. ;
Pashkovskaya, A. A. ;
Pletjushkina, O. Yu. ;
Pustovidko, A. V. ;
Roginsky, V. A. ;
Rokitskaya, T. I. ;
Ruuge, E. K. ;
Saprunova, V. B. ;
Severina, I. I. ;
Simonyan, R. A. ;
Skulachev, I. V. ;
Skulachev, M. V. ;
Sumbatyan, N. V. ;
Sviryaeva, I. V. ;
Tashlitsky, V. N. ;
Vassiliev, J. M. ;
Vyssokikh, M. Yu. ;
Yaguzhinsky, L. S. ;
Zamyatnin, A. A., Jr. ;
Skulachev, V. P. .
BIOCHEMISTRY-MOSCOW, 2008, 73 (12) :1273-1287
[4]  
Bai U, 1997, AM J OTOL, V18, P449
[5]   Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 2. Treatment of some ROS- and Age-related diseases (heart arrhythmia, heart infarctions, kidney ischemia, and stroke) [J].
Bakeeva, L. E. ;
Barskov, I. V. ;
Egorov, M. V. ;
Isaev, N. K. ;
Kapelko, V. I. ;
Kazachenko, A. V. ;
Kirpatovsky, V. I. ;
Kozlovsky, S. V. ;
Lakomkin, V. L. ;
Levina, S. B. ;
Pisarenko, O. I. ;
Plotnikov, E. Y. ;
Saprunova, V. B. ;
Serebryakova, L. I. ;
Skulachev, M. V. ;
Stelmashook, E. V. ;
Studneva, I. M. ;
Tskitishvili, O. V. ;
Vasilyeva, A. K. ;
Victorov, I. V. ;
Zorov, D. B. ;
Skulachev, V. P. .
BIOCHEMISTRY-MOSCOW, 2008, 73 (12) :1288-1299
[6]   Mitochondria, oxidants, and aging [J].
Balaban, RS ;
Nemoto, S ;
Finkel, T .
CELL, 2005, 120 (04) :483-495
[7]   NOX3, a superoxide-generating NADPH oxidase of the inner ear [J].
Bánfi, B ;
Malgrange, B ;
Knisz, J ;
Steger, K ;
Dubois-Dauphin, M ;
Krause, KH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (44) :46065-46072
[8]   Prevention of cisplatin-induced hearing loss by administration of a thiosulfate-containing gel to the middle ear in a guinea pig model [J].
Berglin, Cecilia Engmer ;
Pierre, Pernilla Videhult ;
Bramer, Tobias ;
Edsman, Katarina ;
Ehrsson, Hans ;
Eksborg, Staffan ;
Laurell, Goran .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (06) :1547-1556
[9]   Protective effect of pentoxifylline on amikacin-induced ototoxicity in rats [J].
Berkiten, Guler ;
Salturk, Ziya ;
Topaloglu, Ilhan ;
Ugras, Hilmi .
AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2012, 33 (06) :689-692
[10]   Noise protection with N-acetyl-l-cysteine (NAC) using a variety of noise exposures, NAC doses, and routes of administration [J].
Bielefeld, Eric C. ;
Kopke, Richard D. ;
Jackson, Ronald L. ;
Coleman, John K. M. ;
Liu, Jianzhong ;
Henderson, Donald .
ACTA OTO-LARYNGOLOGICA, 2007, 127 (09) :914-919